Abiopharma

🔍 Doygun Eren (Executive)

Company: GATX CORP (GATX)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 1,000 shares of Common Stock at $77.07 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: false | shares_owned_after: 6,323.00 | transaction_form_type: 4
• Sold 1,000 shares of Common Stock at $179.5186 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: false | shares_owned_after: 5,323.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock 401(k) (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 210.00
• Sold 1,000 shares of 2020 NQ Stock Option (Right to Buy) at $77.07 per share (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2027-01-31 | Exercise: 2021-01-31 | equity_swap_involved: false | transaction_form_type: 4

Footnotes:

• F1: Represents the weighted average sale price. The highest price at which shares were sold was $179.8000 and the lowest price at which shares were sold was $179.2900. Information regarding the number of shares sold at each separate price will be made available from the reporting person upon request by the SEC, the issuer or its shareholders.